The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126023751 12602375 1 I 20160725 20160728 20160728 PER US-PFIZER INC-2016361496 PFIZER 47.00 YR F Y 48.99000 KG 20160728 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126023751 12602375 1 PS LYRICA PREGABALIN 1 Oral 75MG BY MOUTH ONCE DAILY Y 21446 75 MG
126023751 12602375 2 SS LYRICA PREGABALIN 1 150 MG, UNK Y 21446 150 MG
126023751 12602375 3 SS CYMBALTA DULOXETINE HYDROCHLORIDE 1 Oral 30 MG, DAILY 0 30 MG CAPSULE
126023751 12602375 4 SS CYMBALTA DULOXETINE HYDROCHLORIDE 1 Oral 60 MG, DAILY 0 60 MG CAPSULE
126023751 12602375 5 SS CYMBALTA DULOXETINE HYDROCHLORIDE 1 Oral TWO 60MG CAPSULES BY MOUTH ONCE DAILY 0 120 MG CAPSULE
126023751 12602375 6 SS ATIVAN LORAZEPAM 1 Oral 0.5 MG, 1X/DAY 0 .5 MG QD
126023751 12602375 7 SS ATIVAN LORAZEPAM 1 Oral TWO 0.5MG PILLS BY MOUTH NIGHTLY 0 1 MG QD
126023751 12602375 8 C SIMVASTATIN. SIMVASTATIN 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126023751 12602375 1 Pain in extremity
126023751 12602375 2 Burning sensation
126023751 12602375 3 Anxiety
126023751 12602375 4 Burning sensation
126023751 12602375 6 Insomnia
126023751 12602375 8 Blood cholesterol increased

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
126023751 12602375 Anxiety
126023751 12602375 Drug ineffective
126023751 12602375 Insomnia
126023751 12602375 Tremor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126023751 12602375 1 201604 0
126023751 12602375 3 201605 0
126023751 12602375 6 201604 0